Charles Elliott Sigal - May 30, 2024 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Director
Signature
/s/ Vanina de Verneuil, Attorney-In-Fact
Stock symbol
VIR
Transactions as of
May 30, 2024
Transactions value $
$0
Form type
4
Date filed
6/3/2024, 12:18 PM
Previous filing
May 20, 2024
Next filing
May 12, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Award $0 +8K +50.61% $0.00 23.8K May 30, 2024 Direct
holding VIR Common Stock 10K May 30, 2024 By Sigal Family Investments, LLC F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Stock Option (Right to Buy) Award $0 +16K $0.00 16K May 30, 2024 Common Stock 16K $10.39 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.